BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

  February 27, 2024 – Proscia®, a leading provider of digital and computational pathology solutions, today announced that Pramana, Inc.,

  February 27, 2024

   · 

  3 min read
• Business

  Atrion Corporation Declares Quarterly Cash Dividend - February 27, 2024

  Atrion Corporation announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock.

  February 27, 2024

   · 

  1 min read
• Business

  Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

  Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI) today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance.

  February 27, 2024

   · 

  19 min read
• Biotech Bay

  Terns Pharmaceuticals to Participate in Upcoming March 2024 Investor Conferences

  Terns Pharmaceuticals, Inc. announced that members of senior management will be participating in the following upcoming investor conferences in March.

  February 27, 2024

   · 

  1 min read
• Business

  PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

  PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2023.

  February 27, 2024

   · 

  13 min read
• Business

  Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

  Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2023.

  February 27, 2024

   · 

  15 min read
• Genetown

  Ginkgo Bioworks Announces Participation in the 44th Annual TD Cowen Health Care Conference

  Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to participate in Cowen’s 44th Annual Health Care Conference on Tuesday, March 5, 2024 at 2:10 p.m. ET.

  February 27, 2024

   · 

  1 min read
• Business

  Veradigm Provides Update on its Financial Restatement Process

  Veradigm Provides Update on its Financial Restatement Process.

  February 27, 2024

   · 

  8 min read
• Genetown

  Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

  Seres Therapeutics, Inc. announced today that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will participate in a panel discussion at the Cowen 44th Annual Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. ET.

  February 27, 2024

   · 

  1 min read
• Genetown

  PureTech to Present at Two Upcoming Investor Conferences - February 27, 2024

  PureTech Health plc today announced that members of the management team will participate at two upcoming investor conferences.

  February 27, 2024

   · 

  3 min read